Some downstream molecules of the PI3K/AKT/mTOR signaling pathway are particularly increased in HCC patients with elevated 2[18F]fluoro-2-deoxy-d-glucose (FDG) uptake, implying that the activation of this pathway might regulate the HCC metabolism [12]. This evidence concerns the gene MTOR and hepatocellular carcinoma.